Caredx and miromatrix announce exclusive partnership to advance research using bioengineered organs for human transplantation

Brisbane, calif. & eden prairie, minn.--(business wire)--caredx, inc. (nasdaq: cdna) and miromatrix medical inc. (“miromatrix”) (nasdaq: miro) – today announced an exclusive partnership aimed at advancing the next wave of innovation using fully transplantable human bioengineered organs.

CDNA Ratings Summary

CDNA Quant Ranking